Australia markets closed

Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
21.17+0.30 (+1.44%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,767,177
2,782,696
2,200,023
1,594,016
1,319,652
Cost of revenue
2,092,783
2,109,774
1,695,339
1,226,885
858,181
Gross profit
674,394
672,921
504,684
367,131
461,472
Operating expenses
Research development
136,428
124,276
99,713
84,229
65,034
Selling general and administrative
77,616
68,238
58,248
48,473
35,993
Total operating expenses
269,905
247,315
197,376
156,085
115,652
Operating income or loss
404,489
425,606
307,307
211,046
345,820
Interest expense
40,299
37,147
14,236
3,896
8,443
Income before tax
407,132
422,403
342,782
254,070
348,518
Income tax expense
44,788
50,019
23,504
17,361
41,351
Income from continuing operations
362,344
372,384
319,278
236,709
307,167
Net income
361,418
371,452
319,278
236,709
307,167
Net income available to common shareholders
361,418
371,452
319,278
236,709
307,167
Basic EPS
1.49
1.63
1.40
1.07
2.51
Diluted EPS
1.49
1.63
1.40
1.07
2.51
Basic average shares
227,735
227,885
228,056
221,223
122,517
Diluted average shares
227,735
227,885
228,056
221,223
122,517